Supply Chain Intelligence

Purple Biotech Ltd Supply Chain

PPBT supply chain intelligence for Purple Biotech Ltd: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

PPBT ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

4Suppliers
2Customers
1Debt Items
20Related Chains

Purple Biotech Ltd Suppliers

TickerNameConfidenceEvidence
BMY Bristol-Myers Squibb Company 92% We entered into a clinical collaboration and supply agreement with Bristol Myers Squibb Company (NYSE:BMY) for the phase 1/2 study of CM24 in combination with a programmed cell death protein 1 (PD-1)…
BMY Bristol-Myers Squibb Company 92% Reciprocal relationship from BMY graph: Reciprocal relationship from PPBT graph: Reciprocal relationship from BMY graph: Reciprocal relationship from PPBT graph: Reciprocal relationship from BMY grap…
CELG-RI CELG-RI 72% letion of these trials and adversely affect our ability to advance the development of our therapeutic candidates. Even if we can enroll a sufficient number of patients in our clinical trials, delays …
CELG-RI CELG-RI 72% Reciprocal relationship from CELG-RI graph: Reciprocal relationship from PPBT graph: letion of these trials and adversely affect our ability to advance the development of our therapeutic candidates. …

Purple Biotech Ltd Customers

TickerNameConfidenceEvidence
CELG-RI CELG-RI 72% letion of these trials and adversely affect our ability to advance the development of our therapeutic candidates. Even if we can enroll a sufficient number of patients in our clinical trials, delays …
CELG-RI CELG-RI 72% Reciprocal relationship from CELG-RI graph: Reciprocal relationship from PPBT graph: Reciprocal relationship from CELG-RI graph: Reciprocal relationship from PPBT graph: Reciprocal relationship from …

Purple Biotech Ltd Debt Obligations

InstrumentDescriptionConfidenceEvidence
PPBT-DEBT Debt stack $244,000 90% Market cache reports total debt of $244,000.

Purple Biotech Ltd Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Purple Biotech Ltd.

Purple Biotech Ltd Ownership

HolderNameConfidenceEvidence
PPBT-OWNER-MORGAN-STANLEY MORGAN STANLEY 90% 13F overlay lists MORGAN STANLEY as top holder; 2 tracked holders.

Purple Biotech Ltd Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
FISI Financial Institutions, Inc. 100.00 2
MMTX Miluna Acquisition Corp 100.00 2
ONMD OneMedNet Corporation 100.00 2
BMY Bristol-Myers Squibb Company 100.00 1 ['supplier']
CELG-RI BRISTOL MYERS SQUIBB CO 100.00 1 ['customer', 'supplier']
CYTK Cytokinetics, Incorporated 50.00 2
EMMA Emmaus Life Sciences, Inc. 50.00 2
ANL Adlai Nortye Ltd. 50.00 2
CHRS Coherus Oncology, Inc. 50.00 2
CPMV Mosaic ImmunoEngineering, Inc. 50.00 2
DYN Dyne Therapeutics, Inc. 50.00 2
EDIT Editas Medicine, Inc. 50.00 2
FULC Fulcrum Therapeutics, Inc. 50.00 2
CUE Cue Biopharma, Inc. 50.00 2
FATE Fate Therapeutics, Inc. 50.00 2
TLSA Tiziana Life Sciences Ltd 50.00 2
AGEN Agenus Inc. 50.00 2
AZN AstraZeneca PLC 50.00 2
ALLR Allarity Therapeutics, Inc. 50.00 2
SDGR Schrödinger, Inc. 50.00 2
View PPBT supply chain intel →

Explore the full interactive supply chain map for Purple Biotech Ltd.

Open PPBT supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map